RDIF: Peer-Reviewed Journal Vaccines Confirms Long-Term Efficacy of Russia's Sputnik V

RDIF: Peer-Reviewed Journal Vaccines Confirms Long-Term Efficacy of Russia's Sputnik V

MOSCOW (Sputnik) – International peer-reviewed medical journal Vaccines has published a Russian study proving the efficacy of Russia-made Sputnik V vaccine against COVID-19 in the long-term, the Russian Direct Investment Fund (RDIF) said on Tuesday.

Sputnik News

South Africa Today – World News – Latin America